Guidance document - Nonprescription topical nasal decongestants labelling standard
This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance document - Nonprescription topical nasal decongestants labelling standardHTMLEnglish publication HTML
-
Guidance document - Nonprescription topical nasal decongestants labelling standardHTMLFrench publication HTML